ALK-Abelló
ALK-Abelló A/S is a global pharmaceutical company specializing in the development and production of allergy immunotherapy products. The company is headquartered in Hørsholm, Denmark and operates in more than 30 countries worldwide. ALK-Abelló is a leader in the field of allergy immunotherapy, providing treatments for allergic conditions such as allergic rhinitis, allergic asthma, and anaphylaxis.
History[edit | edit source]
ALK-Abelló was founded in 1923 by Dr. Kaj Baagøe and Dr. Jørgen Lehmann. The company initially focused on the production of bacterial vaccines but later shifted its focus to allergy immunotherapy. Over the years, ALK-Abelló has expanded its product portfolio and geographical presence through strategic acquisitions and partnerships.
Products[edit | edit source]
ALK-Abelló offers a range of allergy immunotherapy products, including subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). Some of the company's well-known products include:
- GRAZAX® - A tablet-based immunotherapy for grass pollen allergy.
- ACARIZAX® - A tablet-based immunotherapy for house dust mite allergy.
- RAGWITEK® - A tablet-based immunotherapy for ragweed pollen allergy.
- ALK-SQ® - A range of subcutaneous immunotherapy products for various allergens.
Research and Development[edit | edit source]
ALK-Abelló invests significantly in research and development to advance the field of allergy immunotherapy. The company's R&D efforts focus on improving the efficacy and safety of existing treatments, as well as developing new therapies for emerging allergens. ALK-Abelló collaborates with leading academic institutions and research organizations to drive innovation in allergy treatment.
Global Presence[edit | edit source]
ALK-Abelló operates in more than 30 countries, with a strong presence in Europe, North America, and Asia. The company has production facilities in Denmark, France, Spain, and the United States. ALK-Abelló's products are distributed through a network of subsidiaries, distributors, and partners worldwide.
Corporate Social Responsibility[edit | edit source]
ALK-Abelló is committed to corporate social responsibility (CSR) and sustainability. The company focuses on reducing its environmental impact, promoting ethical business practices, and supporting community initiatives. ALK-Abelló also engages in patient advocacy and education to raise awareness about allergic diseases and the benefits of immunotherapy.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
